Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950168-02-000219
Filing Date
2002-02-14
Accepted
2002-02-14 00:00:00
Documents
1
Group Members
BLUEFISH PARTNERS, L.P.JAMES E. DAVERMANLLOYD D. RUTHMARQUETTE GENERAL II, L.P.MARQUETTE VENTURE PARTNERS, II, L.P.MVP II AFFILIATES FUND, L.P.REDFISH PARTNERS, L.P.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT #4 TO SCHEDULE 13G dsc13ga.txt SC 13G/A 27751
  Complete submission text file 0000950168-02-000219.txt   29791
Mailing Address 41 UNIVERSITY DRIVE NEWTON PA 18940
Business Address 41 UNIVERSITY DRIVE NEWTON PA 18940 2155797388
COLLAGENEX PHARMACEUTICALS INC (Subject) CIK: 0001012270 (see all company filings)

EIN.: 521758016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-47825 | Film No.: 02549340
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 500 CORPORATE CENTRE 520 LAKE COOK ROAD SUITE 450 DEERFIELD IL 60015 8474058396
DAVERMAN JAMES E (Filed by) CIK: 0001033489 (see all company filings)